from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0931c/pknD

LFCtreatmentdescriptionclass of inhibitor

-2.494

Amikacinug/mL Amikacintranslation

-3.189

Cap5-10ug/mL Capreomycintranslation

-3.742

Rox10-50 ug/mL Roxithromycintranslation

-0.449

SM2-5 ug/mL Streptomycintranslation

-3.491

Tet5-10 ug/mL Tetracyclinetranslation

-1.105

Rif0.2-5ug/mL Rifampicintranscription

-1.033

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.038

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.099

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.144

CPZ10-50 ug/mL Chlorpromazinerespiration

0.768

Clofazimine10-13 ug/mL Clofaziminerespiration

0.563

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.013

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.494

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.129

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.645

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.131

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.117

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.874

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.123

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.477

KCN5-20 ug/mL Potassium cyaniderespiration

1.313

NaN30.2-2 mM Sodium aziderespiration

-0.423

Nigericin50 uM Nigericinrespiration

0.125

TRC10-150 ug/mL Triclosanrespiration

-0.666

TRZ10-25 ug/mL Thioridazinerespiration

-1.558

Valinomycin0.5-10 uM Valinomycinrespiration

0.115

ZnSO42 mM ZnSO4respiration

-0.590

menadione6-10 ug/mL Menadionerespiration

0.175

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.114

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.134

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.055

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.525

NRP_1Non-replicating persistence stage 1dosRassociated

0.107

Amp0.2mg/mL AmpicillincellWall

-0.110

Cephalexin20-100 ug/mL CephalexincellWall

-0.002

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.061

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.173

EMB10-20 ug/mL EthambutolcellWall

0.136

Eta12-40 ug/mL EthionamidecellWall

-0.086

INH0.2-0.4 ug/mL IsoniazidcellWall

0.416

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.147

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.050

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.971

BZA0.12 mg/mL BenzamidearomaticAmides

0.609

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.446

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.833

H2O24 mM hydrogen peroxideDNAdamaging

0.134

Levo10 ug/mL LevofloxacinDNAdamaging

-0.164

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.492

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.198

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.354

UVUV-irradiationDNAdamaging

-0.971

ARP41-4 ug/mL Antitubercular compound ARP4?

0.104

Antimycin12.5-50 ug/mL Antimycin A?

0.019

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.840

PA_110-50 ug/mL Antitubercular compound PA-1?

0.738

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.387

PA8240.2-2 ug/mL PA-824?

1.234

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.376

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.151

Verapamil50 uM Verapamil?

0.107

mercaptoethanol2 mM 2-Mercaptoethanol?

0.259

methoxatin10-20 ug/mL Methoxatin?